A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy

PHASE4CompletedINTERVENTIONAL

Enrollment

409

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

June 30, 2007

Conditions

EpilepsySeizuresEpilepsies, PartialEpilepsy, GeneralizedSeizures, Tonic-Clonic

Interventions

DRUG

Topiramate

All Listed Sponsors

collaborator

Ortho-McNeil Neurologics, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00266604 - A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy | Biotech Hunter | Biotech Hunter